Q&A: Fu­ji­film Diosynth’s new CEO Lars Pe­tersen talks pri­or­i­ties and plans for the CD­MO

Last year
People
Manufacturing

UK med­ical re­search group re­veals £100M rare dis­eases pro­gram; Al­lar­i­ty an­nounces $11M of­fer­ing

Last year
News Briefing

Aslan touts da­ta for com­peti­tor to Dupix­ent as it seeks new part­ners

Last year
R&D

Pfiz­er in­vests $25M in­to Cari­bou Bio­sciences, gets first dibs on off-the-shelf CAR-T ther­a­py for mul­ti­ple myelo­ma

Last year
Deals
Cell/Gene Tx

FDA lifts par­tial hold on Curis' PhI/II leukemia study as biotech rais­es $15M 

Last year
Financing
FDA+

Gal­va­nize turns to lay­offs less than a year af­ter merg­ing three Ap­ple Tree com­pa­nies, rais­ing $100M

Last year
People
Startups

Te­va re­port­ed­ly con­sid­er­ing sale of API unit

Last year
Deals
Manufacturing

Pen­ny stock biotech His­to­gen stops de­vel­op­ment pro­grams and con­sid­ers strate­gic al­ter­na­tives

Last year
R&D

Ex­clu­sive: Saris­sa's board push drew lit­tle sup­port in Alk­er­mes share­hold­er vote

Last year
People

Brii Bio­sciences snaps up VBI Vac­ci­nes' HBV pro­grams in ex­pand­ed deal, jump­ing in­to com­mer­cial mode

Last year
Deals

Sin­ga­pore can­cer cell ther­a­py start­up Tes­sa Ther­a­peu­tics to shut down

Last year
People
Cell/Gene Tx

Aus­tralia re­clas­si­fies psy­che­delics to fa­cil­i­tate med­ical use, as ad­vo­cates push for sim­i­lar move in US

Last year
R&D
Pharma

HTA changes at EU lev­el could slow the up­take of new cell and gene ther­a­pies, in­dus­try group warns

Last year
Cell/Gene Tx

J&J leads phar­ma com­pa­nies in brand rank­ings, top­ping Roche, Bay­er and Pfiz­er amid over­all in­dus­try de­cline

Last year
Pharma
Marketing

Sanofi inks deal to help Sau­di Ara­bia man­u­fac­ture vac­cines lo­cal­ly

Last year
Deals
Manufacturing

Bernie Sanders wants to add price caps to ther­a­pies de­vel­oped with BAR­DA, CDC funds

Last year
FDA+
Law

Lil­ly to buy Eu­ro­pean ADC biotech; Ab­b­Vie ends SHP2 work with Ja­co­bio

Last year
News Briefing

Mod­er­na pens deal with Chi­na to make mR­NA med­i­cines that 'will not be ex­port­ed'

Last year
R&D

Mod­er­na files RSV vac­cine for old­er adults in US and Eu­rope

Last year
FDA+

Pfiz­er, Sam­sung Bi­o­log­ics build on biosim­i­lar deals now worth $897M

Last year
Deals
Manufacturing

F-star bags third Take­da tie-up in a year with mul­ti-spe­cif­ic an­ti­bod­ies for can­cer

Last year
Deals

'The more over­hype, the hard­er you fal­l': Schrödinger CEO warns on AI craze

Last year
R&D

FDA re­jects Am­neal's ex­tend­ed-re­lease Parkin­son's treat­ment, seek­ing more safe­ty da­ta

Last year
FDA+

The H1 pic­ture: Biotech’s vi­tal signs show some life — with one big ex­cep­tion

Last year
Bioregnum
First page Previous page 316317318319320321322 Next page Last page
A service from the Financial Times